<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36903260</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Proteomics Analysis of Lymphoblastoid Cell Lines from Patients with Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2014</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules28052014</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) consists of the progressive degeneration of motor neurons, caused by poorly understood mechanisms for which there is no cure. Some of the cellular perturbations associated with ALS can be detected in peripheral cells, including lymphocytes from blood. A related cell system that is very suitable for research consists of human lymphoblastoid cell lines (LCLs), which are immortalized lymphocytes. LCLs that can be easily expanded in culture and can be maintained for long periods as stable cultures. We investigated, on a small set of LCLs, if a proteomics analysis using liquid chromatography followed by tandem mass spectrometry reveals proteins that are differentially present in ALS versus healthy controls. We found that individual proteins, the cellular and molecular pathways in which these proteins participate, are detected as differentially present in the ALS samples. Some of these proteins and pathways are already known to be perturbed in ALS, while others are new and present interest for further investigations. These observations suggest that a more detailed proteomics analysis of LCLs, using a larger number of samples, represents a promising approach for investigating ALS mechanisms and to search for therapeutic agents. Proteomics data are available via ProteomeXchange with identifier PXD040240.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Whitham</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4799-8096</Identifier><AffiliationInfo><Affiliation>Biochemistry &amp; Proteomics Laboratories, Department of Chemistry &amp; Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY 13699-5810, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belenkiy</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029-6574, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darie</LastName><ForeName>Costel C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-6402-2311</Identifier><AffiliationInfo><Affiliation>Biochemistry &amp; Proteomics Laboratories, Department of Chemistry &amp; Biomolecular Science, Clarkson University, 8 Clarkson Avenue, Potsdam, NY 13699-5810, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radu</LastName><ForeName>Aurelian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029-6574, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36903260</ArticleId><ArticleId IdType="pmc">PMC10004326</ArticleId><ArticleId IdType="doi">10.3390/molecules28052014</ArticleId><ArticleId IdType="pii">molecules28052014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., Van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott E.O., Malek A.M., Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb. Clin. Neurol. 2016;138:225&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Jones A.R., Sproviero W., Shatunov A., Opie-Martin S., Morrison K.E., Shaw P.J., Shaw C.E., Fogh I. C9orf72 intermediate expansions of 24&#x2013;30 repeats are associated with ALS. Acta Neuropathol. Commun. 2019;7:1&#x2013;7. doi: 10.1186/s40478-019-0724-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski Jr T., Bosco D., Leclerc A., Tamrazian E., Vanderburg C., Russ C., Davis A., Gilchrist J., Kasarskis E., Munsat T. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulisz D. Disease state overview. Am. J. Manag. Care. 2018;24:S320&#x2013;S326.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207670</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Garofalo M., Scarian E., Dragoni F., Garau J., Di Gerlando R., Diamanti L., Bordoni M., Gagliardi S. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022;23:2580. doi: 10.3390/ijms23052580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052580</ArticleId><ArticleId IdType="pmc">PMC8910056</ArticleId><ArticleId IdType="pubmed">35269723</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Arozamena S., De Munain A. Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis. Neural Regen. Res. 2020;15:2043. doi: 10.4103/1673-5374.282257.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.282257</ArticleId><ArticleId IdType="pmc">PMC7716046</ArticleId><ArticleId IdType="pubmed">32394958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain T., Mulherkar R. Lymphoblastoid cell lines: A continuous in vitro source of cells to study carcinogen sensitivity and DNA repair. Int. J. Mol. Cell. Med. 2012;1:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920499</ArticleId><ArticleId IdType="pubmed">24551762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui-Yuen J., McAllister S., Koganti S., Hill E., Bhaduri-McIntosh S. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines. JoVE (J. Vis. Exp.) 2011;57:e3321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3308597</ArticleId><ArticleId IdType="pubmed">22090023</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Drufuca L., Diamanti L., Sproviero D., Trotti R., Bernuzzi S., La Salvia S., Gagliardi S., Ceroni M. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis. Model. Mech. 2018;11:dmm031625. doi: 10.1242/dmm.031625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031625</ArticleId><ArticleId IdType="pmc">PMC5897724</ArticleId><ArticleId IdType="pubmed">29419416</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley S.J., Fisher P. Lymphoblastoid cell lines as models to study mitochondrial function in neurological disorders. Int. J. Mol. Sci. 2021;22:4536. doi: 10.3390/ijms22094536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094536</ArticleId><ArticleId IdType="pmc">PMC8123577</ArticleId><ArticleId IdType="pubmed">33926115</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Bury J.J., Heath P.R., Wyles M., Higginbottom A., Gelsthorpe C., Highley J.R., Hautbergue G., Rattray M., Kirby J. C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis. PLoS ONE. 2015;10:e0127376. doi: 10.1371/journal.pone.0127376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127376</ArticleId><ArticleId IdType="pmc">PMC4446097</ArticleId><ArticleId IdType="pubmed">26016851</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E.C., Carter E.K., Dammer E.B., Duong D.M., Gerasimov E.S., Liu Y., Liu J., Betarbet R., Ping L., Yin L. Large-scale deep multi-layer analysis of Alzheimer&#x2019;s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 2022;25:213&#x2013;225. doi: 10.1038/s41593-021-00999-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00999-y</ArticleId><ArticleId IdType="pmc">PMC8825285</ArticleId><ArticleId IdType="pubmed">35115731</ArticleId></ArticleIdList></Reference><Reference><Citation>Channaveerappa D., Lux J.C., Wormwood K.L., Heintz T.A., McLerie M., Treat J.A., King H., Alnasser D., Goodrow R.J., Ballard G., et al. Atrial electrophysiological and molecular remodelling induced by obstructive sleep apnoea. J. Cell Mol. Med. 2017;21:2223&#x2013;2235. doi: 10.1111/jcmm.13145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13145</ArticleId><ArticleId IdType="pmc">PMC5571519</ArticleId><ArticleId IdType="pubmed">28402037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupree E.J., Crimmins B.S., Holsen T.M., Darie C.C. Proteomic Analysis of the Lake Trout (Salvelinus namaycush) Liver Identifies Proteins from Evolutionarily Close and -Distant Fish Relatives. Proteomics. 2019;19:e1800429. doi: 10.1002/pmic.201800429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800429</ArticleId><ArticleId IdType="pubmed">31578773</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupree E.J., Crimmins B.S., Holsen T.M., Darie C.C. Developing Well-Annotated Species-Specific Protein Databases Using Comparative Proteogenomics. Adv. Exp. Med. Biol. 2019;1140:389&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">31347060</ArticleId></ArticleIdList></Reference><Reference><Citation>Neagu A.-N., Jayathirtha M., Baxter E., Donnelly M., Petre B.A., Darie C.C. Applications of Tandem Mass Spectrometry (MS/MS) in Protein Analysis for Biomedical Research. Molecules. 2022;27:2411. doi: 10.3390/molecules27082411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27082411</ArticleId><ArticleId IdType="pmc">PMC9031286</ArticleId><ArticleId IdType="pubmed">35458608</ArticleId></ArticleIdList></Reference><Reference><Citation>Neagu A.-N., Whitham D., Buonanno E., Jenkins A., Alexa-Stratulat T., Tamba B.I., Darie C.C. Proteomics and its applications in breast cancer. Am. J. Cancer Res. 2021;11:4006&#x2013;4049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493401</ArticleId><ArticleId IdType="pubmed">34659875</ArticleId></ArticleIdList></Reference><Reference><Citation>Darie C.C., Deinhardt K., Zhang G., Cardasis H.S., Chao M.V., Neubert T.A. Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry. Proteomics. 2011;11:4514&#x2013;4528. doi: 10.1002/pmic.201000819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201000819</ArticleId><ArticleId IdType="pmc">PMC3563432</ArticleId><ArticleId IdType="pubmed">21932443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngounou Wetie A.G., Sokolowska I., Channaveerappa D., Dupree E.J., Jayathirtha M., Woods A.G., Darie C.C. Proteomics and Non-proteomics Approaches to Study Stable and Transient Protein-Protein Interactions. Adv. Exp. Med. Biol. 2019;1140:121&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">31347045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngounou Wetie A.G., Sokolowska I., Woods A.G., Roy U., Deinhardt K., Darie C.C. Protein-protein interactions: Switch from classical methods to proteomics and bioinformatics-based approaches. Cell. Mol. Life Sci. 2014;71:205&#x2013;228. doi: 10.1007/s00018-013-1333-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1333-1</ArticleId><ArticleId IdType="pubmed">23579629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayathirtha M., Neagu A.N., Whitham D., Alwine S., Darie C.C. Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer. Am. J. Cancer Res. 2022;12:4373&#x2013;4398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548009</ArticleId><ArticleId IdType="pubmed">36225631</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayathirtha M., Neagu A.N., Whitham D., Alwine S., Darie C.C. Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer. Am. J. Cancer Res. 2022;12:1784&#x2013;1823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077082</ArticleId><ArticleId IdType="pubmed">35530281</ArticleId></ArticleIdList></Reference><Reference><Citation>Willforss J., Chawade A., Levander F. NormalyzerDE: Online tool for improved normalization of omics expression data and high-sensitivity differential expression analysis. J. Proteome Res. 2018;18:732&#x2013;740. doi: 10.1021/acs.jproteome.8b00523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00523</ArticleId><ArticleId IdType="pubmed">30277078</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlmann-Eltze C., Anders S. proDA: Probabilistic dropout analysis for identifying differentially abundant proteins in label-free mass spectrometry. Biorxiv. 2020:661496.</Citation></Reference><Reference><Citation>Suomi T., Seyednasrollah F., Jaakkola M.K., Faux T., Elo L.L. ROTS: An R package for reproducibility-optimized statistical testing. PLoS Comput. Biol. 2017;13:e1005562. doi: 10.1371/journal.pcbi.1005562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005562</ArticleId><ArticleId IdType="pmc">PMC5470739</ArticleId><ArticleId IdType="pubmed">28542205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D., Ayala V., Granado-Serrano A.B., Jove M., Torres P., Boada J., Cabre R., Ramirez-Nunez O., Gonzalo H., Soler-Cantero A., et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol. Dis. 2016;88:148&#x2013;160. doi: 10.1016/j.nbd.2016.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.01.007</ArticleId><ArticleId IdType="pubmed">26805387</ArticleId></ArticleIdList></Reference><Reference><Citation>Iridoy M.O., Zubiri I., Zelaya M.V., Martinez L., Aus&#xed;n K., Lachen-Montes M., Santamar&#xed;a E., Fernandez-Irigoyen J., Jeric&#xf3; I. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Int. J. Mol. Sci. 2019;20:4. doi: 10.3390/ijms20010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010004</ArticleId><ArticleId IdType="pmc">PMC6337647</ArticleId><ArticleId IdType="pubmed">30577465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Rangaswamy S., Kodavati M., Mitra J., Guo W., Guerrero E.N., Van Den Bosch L., Hegde M.L. RT2 PCR array screening reveals distinct perturbations in DNA damage response signaling in FUS-associated motor neuron disease. Mol. Brain. 2019;12:1&#x2013;5. doi: 10.1186/s13041-019-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0526-4</ArticleId><ArticleId IdType="pmc">PMC6894127</ArticleId><ArticleId IdType="pubmed">31801573</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoni E., Bremang M., Mitra V., Zubiri I., Jung S., Lu C.H., Adiutori R., Lombardi V., Russell C., Koncarevic S., et al. Combined tissue-fluid proteomics to unravel phenotypic variability in amyotrophic lateral sclerosis. Sci. Rep. 2019;9:1&#x2013;16. doi: 10.1038/s41598-019-40632-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40632-4</ArticleId><ArticleId IdType="pmc">PMC6418138</ArticleId><ArticleId IdType="pubmed">30872628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J.N., Mech A.M., Aktar T., Zhang Y., Schiavo G. Altered sensory neuron development in CMT2D mice is site-specific and linked to increased GlyRS levels. Front. Cell. Neurosci. 2020;14:232. doi: 10.3389/fncel.2020.00232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00232</ArticleId><ArticleId IdType="pmc">PMC7431706</ArticleId><ArticleId IdType="pubmed">32848623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.E., Phipson B., Wu D.I., Hu Y., Law C.W., Shi W., Smyth G.K. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. doi: 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell J.A., Wright L.J., Armstrong E.A., Denu J.M. Benchmarking quantitative performance in label-free proteomics. ACS Omega. 2021;6:2494&#x2013;2504. doi: 10.1021/acsomega.0c04030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.0c04030</ArticleId><ArticleId IdType="pmc">PMC7859943</ArticleId><ArticleId IdType="pubmed">33553868</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.Y., Lopez-Gonzalez R., Krishnan G., Phillips H.L., Li A.N., Seeley W.W., Yao W.D., Almeida S., Gao F.B. C9ORF72-ALS/FTD-associated poly (GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukahara A., Hosokawa T., Nishioka D., Kotani T., Ishida S., Takeuchi T., Kimura F., Arawaka S. Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy. Sci. Rep. 2021;11:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613178</ArticleId><ArticleId IdType="pubmed">34819571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushkevich Y.N., Pashkouskaya I., Likhachev S. Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis. Zhurnal Nevrol. I Psikhiatrii Im. SS Korsakova. 2018;118:75&#x2013;80. doi: 10.17116/jnevro20181185175.</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/jnevro20181185175</ArticleId><ArticleId IdType="pubmed">29927408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A., Green J., Pollard Jr J., Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523&#x2013;530. doi: 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E., Tramacere I., Antonini G., Borghero G., Capasso M., Caponnetto C., Chi&#xf2; A., Corbo M., Eleopra R., Filosto M., et al. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) BMJ Open. 2017;7:e015434. doi: 10.1136/bmjopen-2016-015434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015434</ArticleId><ArticleId IdType="pmc">PMC5724081</ArticleId><ArticleId IdType="pubmed">28801400</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Van Den Bosch L. The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:12175. doi: 10.3390/ijms222212175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212175</ArticleId><ArticleId IdType="pmc">PMC8620263</ArticleId><ArticleId IdType="pubmed">34830069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira P.A. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration. Cell. Mol. Life Sci. 2019;76:2247&#x2013;2273. doi: 10.1007/s00018-019-03029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03029-0</ArticleId><ArticleId IdType="pmc">PMC6531325</ArticleId><ArticleId IdType="pubmed">30742233</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Van Damme P., Van Den Bosch L. Inside out: The role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 2016;132:159&#x2013;173. doi: 10.1007/s00401-016-1586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1586-5</ArticleId><ArticleId IdType="pmc">PMC4947127</ArticleId><ArticleId IdType="pubmed">27271576</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm C.G., Lum J.S., Farrawell N.E., Yerbury J.J. Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis? Neural Regen. Res. 2022;17:2218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9083156</ArticleId><ArticleId IdType="pubmed">35259837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Xi Z., Saez-Atienzar S., Chia R., Moreno D., Sato C., Montazer Haghighi M., Traynor B.J., Zinman L., Rogaeva E. Combined epigenetic/genetic study identified an ALS age of onset modifier. Acta Neuropathol. Commun. 2021;9:1&#x2013;9. doi: 10.1186/s40478-021-01183-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01183-w</ArticleId><ArticleId IdType="pmc">PMC8066440</ArticleId><ArticleId IdType="pubmed">33892821</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino A., Rucco R., Stillitano I., Bonavita S., Grimaldi M., Minino R., Pesoli M., Trojsi F., d&#x2019;Ursi A.M., Sorrentino G., et al. In amyotrophic lateral sclerosis blood cytokines are altered, but do not correlate with changes in brain topology. Brain Connect. 2020;10:411&#x2013;421. doi: 10.1089/brain.2020.0741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2020.0741</ArticleId><ArticleId IdType="pubmed">32731760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensel N., Claus P. The actin cytoskeleton in SMA and ALS: How does it contribute to motoneuron degeneration? Neuroscientist. 2018;24:54&#x2013;72. doi: 10.1177/1073858417705059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858417705059</ArticleId><ArticleId IdType="pubmed">28459188</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampetruzzi A., Danielson E.W., Gumina V., Jeon M., Boopathy S., Brown R.H., Ratti A., Landers J.E., Fallini C. Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nat. Commun. 2019;10:1&#x2013;15. doi: 10.1038/s41467-019-11837-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11837-y</ArticleId><ArticleId IdType="pmc">PMC6707192</ArticleId><ArticleId IdType="pubmed">31444357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulgen E., Ozisik O., Sezerman O. pathfindR: An R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front. Genet. 2019;10:858. doi: 10.3389/fgene.2019.00858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00858</ArticleId><ArticleId IdType="pmc">PMC6773876</ArticleId><ArticleId IdType="pubmed">31608109</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:1&#x2013;16. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.C., Ramaswami G., Geschwind D. Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci. Rep. 2021;11:1&#x2013;14. doi: 10.1038/s41598-021-85061-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85061-4</ArticleId><ArticleId IdType="pmc">PMC7970949</ArticleId><ArticleId IdType="pubmed">33707641</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheijen M.H., Peviani M., Hendricusdottir R., Bell E.M., Lammens M., Smit A.B., Bendotti C., Van Minnen J. Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e87255. doi: 10.1371/journal.pone.0087255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087255</ArticleId><ArticleId IdType="pmc">PMC3907527</ArticleId><ArticleId IdType="pubmed">24498056</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., D&#x2019;Amico R., Zucchi E., Gessani A., Fini N., Fasano A., Caponnetto C., Chi&#xf2; A., Dalla Bella E., Lunetta C., et al. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) Medicine. 2018;97:e11119. doi: 10.1097/MD.0000000000011119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011119</ArticleId><ArticleId IdType="pmc">PMC6024184</ArticleId><ArticleId IdType="pubmed">29901635</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H., Kato M., Asada R., Yamashita A., Hayata D., Adachi K., Aoki M. Safety, tolerability, and pharmacodynamics of intrathecal injection of recombinant human HGF (KP-100) in subjects with amyotrophic lateral sclerosis: A phase I trial. J. Clin. Pharmacol. 2019;59:677&#x2013;687. doi: 10.1002/jcph.1355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.1355</ArticleId><ArticleId IdType="pubmed">30536581</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cognata V., Gentile G., Aronica E., Cavallaro S. Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain Regions. Cells. 2020;9:159. doi: 10.3390/cells9010159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010159</ArticleId><ArticleId IdType="pmc">PMC7017305</ArticleId><ArticleId IdType="pubmed">31936368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagara Y., Tateishi T., Yamasaki R., Hayashi S., Kawamura M., Kikuchi H., Iinuma K.M., Tanaka M., Iwaki T., Matsushita T., et al. Impaired Cytoplasmic&#x2013;Nuclear Transport of Hypoxia-Inducible Factor-1&#x3b1; in Amyotrophic Lateral Sclerosis. Brain Pathol. 2013;23:534&#x2013;546. doi: 10.1111/bpa.12040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12040</ArticleId><ArticleId IdType="pmc">PMC8029229</ArticleId><ArticleId IdType="pubmed">23368766</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Gosset P., Kluza J., Brunaud-Danel V., Lassalle P., Marchetti P., Defebvre L., Dest&#xe9;e A., Devos D. Deregulation of the hypoxia inducible factor-1&#x3b1; pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience. 2011;172:110&#x2013;117. doi: 10.1016/j.neuroscience.2010.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.10.040</ArticleId><ArticleId IdType="pubmed">20977930</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupree E.J., Goodwin A., Darie C.C., Boolani A. A Pilot Exploratory Proteomics Investigation of Mental Fatigue and Mental Energy. Adv. Exp. Med. Biol. 2019;1140:601&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">31347074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>